Hiv 1 Collection

HIV-1 protease and inhibitor F006 / 9773
HIV-1 protease and inhibitor. Molecular model of the enzyme HIV-1 protease (pink and blue ribbons) bound to an inhibitor molecule (centre)

HIV reverse transcription enzyme F006 / 9684
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme found in HIV (the human immunodeficiency virus) bound to the inhibitor nevirapine

HIV DNA and transcription factor F006 / 9680
HIV DNA and transcription factor. Molecular model of DNA (deoxyribonucleic acid) from HIV-1 (human immunodeficiency virus type 1) complexed with the transcription factor kappa B

HIV antibody therapy, molecular model F006 / 9622
HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (green) as it interacts with a human white blood cell surface protein (CD4)

HIV reverse transcription enzyme F006 / 9606
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme (pink) found in HIV (the human immunodeficiency virus)

Reverse transcriptase and inhibitor F006 / 9519
Reverse transcriptase and inhibitor. Molecular model of HIV reverse transcriptase complexed with a non-nucleoside reverse transcriptase inhibitor drug

HIV reverse transcription enzyme F006 / 9494
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme (blue and green) found in HIV (the human immunodeficiency virus)

HIV reverse transcription enzyme F006 / 9385
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme found in HIV (the human immunodeficiency virus) bound to the inhibitor nevirapine

HIV reverse transcription enzyme F006 / 9360
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme found in HIV (the human immunodeficiency virus)

HIV nucleocapsid protein molecule F006 / 9219
HIV nucleocapsid protein. Molecular model of the nucleocapsid protein (yellow) from HIV-1 (human immunodeficiency virus-type 1) complexed with the Psi RNA (ribonucleic acid) packaging element (orange)

HIV antibody therapy, molecular model C018 / 9193
HIV antibody therapy. 3D model of the interaction of the HIV surface protein gp120 as it interacts with a human white blood cell surface protein (CD4) and the anti-HIV antibody (17b)

HIV antibody and glycoprotein complex. Molecular model of the anti-human immunodeficiency virus type 1 (anti-HIV-1) antibody 2F5 in complex with the gp41 envelope glycoprotein of HIV-1

HIV-1 polypurine tract, molecular model C015 / 5821
HIV-1 polypurine tract. Molecular model of the polypurine tract (PPT, red) from human immunodeficiency virus-1 (HIV-1) complexed with reverse transcriptase (green)

HIV reverse transcription enzyme C013 / 9613
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme found in HIV (the human immunodeficiency virus)

HIV reverse transcription enzyme C013 / 8998
HIV reverse transcription enzyme. Molecular model of the reverse transcriptase enzyme (orange and blue) found in HIV (the human immunodeficiency virus)

HIV antibody therapy, molecular model C013 / 7908
HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (yellow, bottom right) as it interacts with a human white blood cell surface protein (CD4, green)

Illustration of the HIV retrovirus, black b / ground
HIV retrovirus. Schematic illustration of the structure of a retrovirus, such as the HIV-1 virus that causes AIDS. At centre are RNA strands (red) making up the viral genetic material

Illustration of HIV retrovirus, white background
HIV retrovirus. Schematic illustration of the structure of a retrovirus, such as the HIV-1 virus that causes AIDS. At centre are RNA strands (red) making up the viral genetic material

Computer graphic of a DNA molecule from HIV virus
DNA molecule. Computer graphic of a molecule of Deoxyribonucleic Acid (DNA). DNA encodes an organisms genetic information

HIV reverse transcriptase enzyme
Artwork of a molecular model of the HIV-1 virus reverse transcriptase enzyme. This enzyme is a protein from the human immunodeficiency virus (HIV) that causes AIDS

HIV antibody therapy. Molecular model of the interaction of the HIV surface protein gp120 (green, lower right) as it interacts with a human white blood cell surface protein (CD4, blue)

All Professionally Made to Order for Quick Shipping

"HIV-1: Unraveling the Intricacies of Reverse Transcription Enzyme and Beyond" In the world of virology, HIV-1 stands as a formidable foe, constantly challenging scientists to explore its intricate mechanisms. At the heart of this notorious virus lies the HIV reverse transcription enzyme, an essential player in its replication cycle. One fascinating aspect is the interplay between HIV-1 protease and inhibitor F006 / 9773. Researchers tirelessly investigate how inhibitors can disrupt viral replication by targeting this specific enzyme. Unlocking these secrets could pave the way for more effective antiretroviral therapies. Another critical component is the HIV DNA and transcription factor F006 / 9680, which plays a pivotal role in converting viral RNA into DNA within host cells. Understanding this process holds immense potential for developing novel therapeutic interventions that target early stages of infection. The molecular model of HIV antibody therapy (F006 / 9622) showcases promising advancements in treatment strategies. By designing antibodies that specifically bind to viral proteins, researchers aim to neutralize their harmful effects and provide new avenues for combating this relentless virus. Continuing our exploration, we delve deeper into understanding reverse transcriptase and inhibitor F006 / 9519 – another vital element in HIV-1's life cycle. Scientists strive to decipher how inhibitors can obstruct reverse transcriptase activity effectively, hindering viral replication at its core. As our journey progresses, we encounter various iterations of the HIV reverse transcription enzyme (F006 / 9494; F006 / 9385; F006 / 9360). These enzymes are key targets for drug development due to their indispensable role in generating viral DNA from RNA templates during infection. Notably, visualizing the structure of the nucleocapsid protein molecule (F006/9219) sheds light on crucial interactions within infected cells. This knowledge fuels ongoing research aimed at disrupting these interactions or exploiting them for therapeutic purposes.